Bisphosphonate therapy for osteogenesis imperfecta

Medicine & Life Sciences

• Osteogenesis Imperfecta 100%
• Diphosphonates 82%
• Bone Density 40%
• Spine 15%
• Pamidronate 14%
• Placebos 13%
• Multiple Fractures 13%
• Zoledronic Acid 13%
• Therapeutics 12%
• Fracture Fixation 11%
• Congresses 9%
• Inborn Errors Metabolism 6%
• Bone Matrix 6%
• Confidence Intervals 5%
• Safety 5%
• Pain 5%
• Bone Development 5%
• Risk Reduction Behavior 5%
• Collagen Type I 5%
• Cystic Fibrosis 4%
• Incidence 4%
• Duration of Therapy 4%
• Inborn Genetic Diseases 4%
• Patient Selection 4%
• PubMed 3%
• Data Analysis 3%
• Aptitude 3%
• Randomized Controlled Trials 3%
• Quality of Life 3%
• Odds Ratio 3%
• Databases 3%
• Growth 2%
• Wounds and Injuries 2%
• Child 2%